Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
27 results
- 3상모집 중· Small Cell Lung Cancer광범위 병기 소세포폐암에서 타를라타맙(피하 vs 정맥)의 3상 시험
Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
리드: 암젠
- 3상모집 중· Primary Immune Thrombocytopenia미치료 일차 면역성 혈소판 감소증 치료를 위한 로미플로스팀 플러스 프레드니소론 대 프레드니소론 단독 연구
A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)
리드: 암젠
- 3상모집 중· Obesity마리데바르트 카프라글루티드의 장기 효능, 안전성 및 내약성을 평가하는 확장 시험 (MARITIME-2-EXTENSION)
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
리드: 암젠
- 3상모집 중· Obesity마리드바르트 카프라글루타이드의 장기 유효성, 안전성 및 내약성 평가 확대 시험(MARITIME-1-EXTENSION)
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
리드: 암젠
- 3상모집 중· Neovascular Age-related Macular Degeneration신생혈관 나이 관련 황반변성 환자에서 ABP 938 8mg 대 아플리버셉트의 효능, 안전성 및 면역원성 평가 연구
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
리드: 암젠
- 3상모집 중· Obesity or Overweight비만 또는 과체중 성인에서 GLP-1RA에서 마리데바르트 카프라글루타이드로의 전환(MARITIME-SWITCH)
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
리드: 암젠
- 3상모집 중· Cardiovascular DiseaseOlpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
리드: 암젠
- 3상모집 중· Osteogenesis ImperfectaPediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta
리드: 암젠
- 3상모집 중· Metastatic Castration-resistant Prostate CancerA Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
리드: 암젠
- 3상모집 중· Atherosclerotic Cardiovascular DiseaseEvaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
리드: 암젠
- 3상모집 중· Heart Failure With Preserved Ejection FractionMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
리드: 암젠
- 3상모집 중· Chronic Obstructive Pulmonary Disease (COPD)A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
리드: 아스트라제네카 · 협력: 암젠
- 3상모집 중· Chronic Obstructive Pulmonary Disease (COPD)A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
리드: 아스트라제네카 · 협력: 암젠
- 3상모집 중· Sjögren's SyndromeA Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
리드: 암젠
- 3상모집 중· Acute Lymphoblastic LeukemiaInterfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
협력: 암젠
- 3상모집 중· Active Juvenile Psoriatic ArthritisApremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
리드: 암젠
- 3상모집 중· Behçet DiseaseApremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease
리드: 암젠
- 3상모집 중· Leukemia, Acute LymphoblasticA Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
협력: 암젠, 화이자
- 3상모집 중· Secondary HyperparathyroidismA Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
리드: 암젠
- 3상모집 중· Secondary HyperparathyroidismA Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
리드: 암젠
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.